Journal of Applied Physiology AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 97: 404-415, 2004; doi:10.1152/japplphysiol.01345.2003
8750-7587/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (72)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tune, J. D.
Right arrow Articles by Feigl, E. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tune, J. D.
Right arrow Articles by Feigl, E. O.

INVITED REVIEW

HIGHLIGHTED TOPICS
Skeletal and Cardiac Muscle Blood Flow

Matching coronary blood flow to myocardial oxygen consumption

Johnathan D. Tune,2 Mark W. Gorman,1 and Eric O. Feigl1

1Department of Physiology and Biophysics, University of Washington, Seattle, Washington 98195; and 2Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112


   ABSTRACT
TOP
 ABSTRACT
OXYGEN AND CARBON DIOXIDE
 ADENOSINE HYPOTHESIS
 KATP CHANNELS
 NITRIC OXIDE
 PROSTAGLANDINS
 ENDOTHELIUM-DERIVED...
 ENDOTHELIN
 MULTIPLE CONTROLLERS
 SYMPATHETIC CONTROL OF CORONARY...
 {beta}-ADRENOCEPTOR-MEDIATED...
 {alpha}-ADRENOCEPTOR-MEDIATED...
 CONCLUSION
 GRANTS
 REFERENCES
 
At rest the myocardium extracts ~75% of the oxygen delivered by coronary blood flow. Thus there is little extraction reserve when myocardial oxygen consumption is augmented severalfold during exercise. There are local metabolic feedback and sympathetic feedforward control mechanisms that match coronary blood flow to myocardial oxygen consumption. Despite intensive research the local feedback control mechanism remains unknown. Physiological local metabolic control is not due to adenosine, ATP-dependent K+ channels, nitric oxide, prostaglandins, or inhibition of endothelin. Adenosine and ATP-dependent K+ channels are involved in pathophysiological ischemic or hypoxic coronary dilation and myocardial protection during ischemia. Sympathetic {beta}-adrenoceptor-mediated feedforward arteriolar vasodilation contributes ~25% of the increase in coronary blood flow during exercise. Sympathetic {alpha}-adrenoceptor-mediated vasoconstriction in medium and large coronary arteries during exercise helps maintain blood flow to the vulnerable subendocardium when cardiac contractility, heart rate, and myocardial oxygen consumption are high. In conclusion, several potential mediators of local metabolic control of the coronary circulation have been evaluated without success. More research is needed.

adenosine; ATP-dependent K+ channels; nitric oxide; norepinephrine; feedback control; feedforward control

THE MYOCARDIUM HAS A VERY limited anaerobic capacity, and the heart is dependent on a continuous supply of oxygen from the coronary circulation. Myocardial oxygen consumption increases whenever there is tachycardia and may increase fivefold in the transition from rest to exercise. Powerful mechanisms increase coronary blood flow whenever myocardial oxygen consumption is increased. Without these mechanisms, decreased cardiac output, hypotension, arrhythmias, and death would result. The purpose of the present paper is to review the mechanisms that match oxygen delivery to myocardial oxygen consumption via coronary blood flow.

There are numerous factors that influence the contractile state of coronary vascular smooth muscle, such as the extracellular potassium and calcium ion concentrations (76). However, this brief review is restricted to factors that have been postulated to be involved in coronary vasodilation when myocardial oxygen consumption is augmented. The dominant influence on coronary blood flow is local metabolic feedback control. As will be seen, despite decades of research the local metabolic coronary controller remains unknown. In contrast, feedforward adrenergic control of coronary blood flow contributes significantly to exercise coronary vasodilation and to maintaining flow to the vulnerable subendocardium. The sine qua non of a negative feedback control mechanism is the presence of an error signal. An error signal is the difference between the momentary value of a sensed variable and a set point. The error signal then activates a mechanism that results in an adjustment that restores the regulated variable back toward the set point in a feedback manner.

Because resting left ventricular myocardial oxygen consumption is great (~60 µl·min–1·g–1) with a high oxygen extraction (~75%) and a low coronary venous oxygen tension (~18 Torr), the error signal is assumed to be related to the balance between oxygen supply and oxygen consumption. The balance between oxygen delivery via coronary flow and myocardial oxygen consumption is given by the coronary venous oxygen tension. Oxygen tension is preferable to oxygen content (or extraction) or hemoglobin saturation because the local metabolic chemical mediator will most likely be sensitive to the thermodynamic potential of oxygen (oxygen tension) rather than blood oxygen content. Also, hemoglobin saturation changes as the hemoglobin dissociation curve shifts with carbon dioxide tension, pH, and temperature.

A useful method for analyzing coronary vascular responses is a graph of coronary venous oxygen tension vs. myocardial oxygen consumption as introduced by Heyndrickx et al. (95) and illustrated in Fig. 1. Line A in Fig. 1 shows the normal modest decline in coronary venous oxygen tension as myocardial oxygen consumption increases from rest to exercise. If this line were horizontal, then the match between oxygen supply and consumption would be perfect despite a severalfold increase in myocardial oxygen consumption. The widening divergence from horizontal of line A reflects an increasing error signal as myocardial oxygen consumption increases. Line B indicates the expected result when a mechanism involved in exercise coronary hyperemia is experimentally inhibited. The key point is the difference in slopes between lines A and B. The logic is that the greater the oxygen metabolism along the x-axis, the greater will be the fall in coronary venous oxygen tensions on the y-axis if local metabolic vasodilation is attenuated. In other words, if the coupling between coronary blood flow and myocardial oxygen consumption is experimentally inhibited, then the error signal will increase as oxygen metabolism increases. Line C in Fig. 1 indicates the expected effect if a tonic vasodilator effect is experimentally blocked. There is a decrease in coronary venous oxygen tension at rest and during exercise without a difference in slopes compared with the normal control line A. In this case, the error signal does not grow larger as oxygen consumption increases.



View larger version (12K):
[in this window]
[in a new window]
  		Fig. 1. Graphs of coronary venous oxygen tension vs. myocardial oxygen consumption are very useful in interpreting coronary vascular responses. Line A shows the normal modest decline in coronary venous oxygen tension as left ventricular myocardial oxygen consumption increases from rest to exercise. Line B shows the expected result if a coronary vasodilator mechanism activated during exercise is inhibited. The key point is the difference in slopes between lines A and B. Line C shows the expected result if a tonic vasodilator mechanism present at rest and during exercise is inhibited. In this case the error signal does not grow larger during exercise, resulting in a line parallel to line A but at lower oxygen tensions.

 
The relationships between myocardial oxygen consumption, coronary blood flow, and coronary venous oxygen tension during exercise for the right and left ventricles are shown in Fig. 2. Figure 2A illustrates that oxygen consumption is less in the right ventricle than in the left ventricle, and this is associated with a higher coronary venous oxygen tension (84, 90, 198, 208). Figure 2A also demonstrates that, as right ventricular oxygen consumption increases from rest to exercise, the initial effect is an increasing oxygen extraction (falling venous oxygen tension). The augmented oxygen extraction in the right ventricle occurs with little change in flow when venous tension is above ~20 Torr, as shown in Fig. 2B. Conversely, in the left ventricle (where resting venous oxygen tension is ~18 Torr), increases in myocardial oxygen consumption result in modest decreases in venous oxygen tension (Fig. 2A) and large increases in coronary flow (Fig. 2B).



View larger version (12K):
[in this window]
[in a new window]
  		Fig. 2. Relationships between myocardial oxygen consumption, coronary blood flow, and coronary venous oxygen tension during exercise for canine right and left ventricles. A: oxygen consumption is lower in the right ventricle than in the left, and this is associated with higher coronary venous oxygen tensions. B: as right ventricular oxygen consumption increases during exercise, the initial response is increased oxygen extraction (decreased venous oxygen tension) with little increase in flow. However, there is an inflection point between oxygen tensions of 15 and 20 Torr at which flow increases sharply with decreasing venous oxygen tension. Resting left ventricular venous oxygen tension is ~18 Torr and sits near this inflection point. These results suggest that the left and right ventricles may share common flow control mechanisms and that a powerful vasodilator mechanism is recruited when coronary venous oxygen tension falls below 15–20 Torr. Data from Refs. 84, 90, 198, 208.

 
The interesting intersection between the right and left ventricles in Fig. 2 suggests that they may share common flow control mechanisms and that a powerful vasodilator mechanism is recruited when coronary venous oxygen tension falls below 15–20 Torr.

The postulated coronary control mechanisms are individually considered below.


   OXYGEN AND CARBON DIOXIDE
TOP
 ABSTRACT
 OXYGEN AND CARBON DIOXIDE
ADENOSINE HYPOTHESIS
 KATP CHANNELS
 NITRIC OXIDE
 PROSTAGLANDINS
 ENDOTHELIUM-DERIVED...
 ENDOTHELIN
 MULTIPLE CONTROLLERS
 SYMPATHETIC CONTROL OF CORONARY...
 {beta}-ADRENOCEPTOR-MEDIATED...
 {alpha}-ADRENOCEPTOR-MEDIATED...
 CONCLUSION
 GRANTS
 REFERENCES
 
The simplest local metabolic vasodilators to consider are oxygen and carbon dioxide. Arterial hypoxemia and hypercarbia both result in coronary vasodilation (25, 76); however, the question is whether local tissue concentrations of these gases control coronary blood flow. Broten et al. (25) used coronary venous oxygen and carbon dioxide tensions as a surrogate for tissue values to correlate with coronary blood flow when arterial blood gases were varied by employing membrane oxygenators. A striking synergistic effect between coronary venous oxygen and carbon dioxide tensions and coronary blood flow was observed. That is, high carbon dioxide levels potentiated the effect of hypoxia and hypoxia potentiated the effect of hypercarbia in a greater than simply additive manner. However, the synergistic effect was able to predict only ~40% of coronary vasodilation during cardiac pacing (25) and ~23% of the conductance change during autoregulation (24). Those correlative experiments do not distinguish between the respiratory gases acting directly on vascular smooth muscle and there being an intermediate transmitter such as adenosine. The lack of 100% correlation between coronary flow and coronary venous respiratory gas tensions suggests that factors other than oxygen and carbon dioxide are involved in coronary control, or that coronary venous values are an incomplete index of tissue values.


   ADENOSINE HYPOTHESIS
TOP
 ABSTRACT
 OXYGEN AND CARBON DIOXIDE
 ADENOSINE HYPOTHESIS
KATP CHANNELS
 NITRIC OXIDE
 PROSTAGLANDINS
 ENDOTHELIUM-DERIVED...
 ENDOTHELIN
 MULTIPLE CONTROLLERS
 SYMPATHETIC CONTROL OF CORONARY...
 {beta}-ADRENOCEPTOR-MEDIATED...
 {alpha}-ADRENOCEPTOR-MEDIATED...
 CONCLUSION
 GRANTS
 REFERENCES
 
In 1963, Berne (20) and Gerlach et al. (81) independently proposed that adenosine is the vasodilatory metabolite that links changes in coronary blood flow to myocardial metabolism. The hypothesis predicts that increases in myocardial oxygen consumption decrease myocardial oxygen tension to stimulate the release of adenosine from cardiomyocytes. The resulting increase in cardiac interstitial adenosine concentration activates coronary vascular smooth muscle adenosine receptors, which increases coronary blood flow and augments oxygen delivery. This increase in oxygen delivery acts to restore myocardial oxygen tension to a normal operating level, thereby decreasing cardiac adenosine production in a negative feedback manner. Thus, in short, the cardiac interstitial concentration of adenosine controls coronary blood flow to match myocardial oxygen delivery with myocardial oxygen consumption, thereby maintaining myocardial oxygen tension within the normal physiological range (21).

Adenosine and local metabolic coronary blood flow control.   Over the past 40 years, numerous investigations have examined the role of adenosine in local metabolic coronary vasodilation during increases in myocardial oxygen consumption (13, 15, 21, 44, 51, 57, 62, 64, 65, 68, 82, 91, 104, 109, 128, 129, 133, 137, 198, 200, 204, 206). Results from these studies are inconsistent in that indexes of cardiac interstitial adenosine concentration were augmented during increased myocardial oxygen consumption in some experiments (13, 68, 82, 108, 132, 202) but not in others (115, 198, 200, 206). One possible explanation for these conflicting results is that the adenosine measurements reported in the early investigations did not reliably estimate the cardiac interstitial concentration of adenosine (16, 198). Blockade of endogenous adenosine receptors does not significantly decrease coronary blood flow at rest or during increases in myocardial oxygen consumption (15, 57, 104, 128, 198, 206). A possible explanation for the failure of adenosine receptor blockade to reduce coronary blood flow is that the cardiac interstitial adenosine concentration increases sufficiently to overcome the competitive receptor blockade, as would be predicted if adenosine were part of a high-gain negative feedback system (91, 94, 134). Therefore, it is apparent that to adequately test the adenosine hypothesis, it is essential to have a reliable estimate of cardiac interstitial adenosine concentration when adenosine receptors are blocked.

Recently, Tune et al. (198) quantitatively examined the contribution of adenosine to local metabolic coronary vasodilation by combining measurements of coronary venous adenosine concentration with adenosine receptor blockade during exercise in chronically instrumented dogs. Myocardial interstitial adenosine concentration was calculated from coronary blood flow, hematocrit, and the adenosine concentrations in arterial and coronary venous plasma using a mathematical model (112, 185). This model has been extensively tested and described (112, 185, 203). In testing this model, Stepp et al. (185) determined that there is a steep dose-response relationship between coronary blood flow and interstitial adenosine concentration and that the threshold for adenosine-mediated vasodilation is ~117 nM. Tune et al. (198) found that coronary venous plasma adenosine concentration was little changed with exercise and the estimated interstitial adenosine concentration remained well below the threshold concentration necessary for coronary vasodilation. In addition, coronary venous and estimated interstitial adenosine concentrations did not increase to overcome the competitive adenosine receptor blockade of either 8-phenyltheophylline or 8-p-sulfophenyltheophylline. These findings indicate that adenosine is not required for local metabolic coronary vasodilation during physiological increases in myocardial oxygen consumption.

Tune et al. (198) also found that adenosine receptor blockade with 8-phenyltheophylline produced a significant decrease in coronary venous PO2 at a given myocardial oxygen consumption, i.e., parallel shift downward in the coronary venous PO2 vs. myocardial oxygen consumption relationship (Fig. 3A). This finding is consistent with earlier studies in humans (64), pigs (57), and dogs (200, 206), but not in a careful study by Bache et al. (15) in which no change was observed with 8-phenyltheophylline. The parallel shift downward suggests that adenosine might exert a tonic vasodilator influence on the coronary circulation at rest and during exercise. However, this finding is at odds with the cardiac adenosine measurements in that the estimated interstitial adenosine concentration remained well below the threshold value necessary for coronary vasodilation (198). This paradoxical finding could be due to a nonspecific effect of 8-phenyltheophylline because degradation of cardiac adenosine by intracoronary adenosine deaminase infusion does not affect coronary venous PO2 in unstressed dogs (111, 128, 139). Regardless of the parallel 8-phenyltheophylline effect, the fact that the slope of the coronary venous PO2 vs. myocardial oxygen consumption relationship was not steepened by adenosine receptor blockade indicates that adenosine is not required for local metabolic coronary vasodilation during exercise.



View larger version (33K):
[in this window]
[in a new window]
  		Fig. 3. Graphs of coronary venous oxygen tension vs. myocardial oxygen consumption at rest and during exercise, under control conditions and after inhibition of several proposed exercise vasodilator mechanisms. A: blockade of adenosine receptors with 8-phenyltheophylline (8-PT). B: blockade of ATP-dependent K+ (KATP) channels with glibenclamide. C: inhibition of nitric oxide synthesis with N{omega}-nitro-L-arginine (LNA). D: simultaneous inhibition of adenosine, KATP channels, and nitric oxide. E: inhibition of prostaglandin synthesis with indomethacin. F: regression lines from the interventions in A–D plotted in 1 graph for comparison. In this panel the control line has been fit to the combined control data points from A–D. Data are from the references noted in each panel.

 
Adenosine and coronary blood flow control during ischemia.   Although adenosine is not responsible for functional coronary hyperemia under normal physiological conditions, adenosine does contribute to coronary vasodilation when the myocardium is ischemic (121). Coronary vasodilation during exercise is significantly reduced by combined degradation of endogenous adenosine with adenosine deaminase and blockade of adenosine receptors with 8-phenyltheophylline in chronically instrumented dogs with a coronary stenosis (coronary perfusion pressure = 40 mmHg) (54, 121). These findings indicate that as long as the change in coronary blood flow is sufficient to prevent ischemia, adenosine release is not elevated and thus does not contribute to local metabolic coronary vasodilation. However, if changes in coronary blood flow do not sufficiently match changes in myocardial metabolism, such as in patients with a critical coronary stenosis, adenosine is released by the ischemic myocytes in an attempt to augment coronary blood flow and oxygen delivery. This increase in cardiac adenosine release not only increases coronary blood flow but has several other effects that decrease myocardial injury during ischemia, as recently reviewed by Headrick et al. (92). The cardioprotective effects of adenosine include 1) decreased myocardial contractility (negative inotropic effect) (17, 26, 43, 48–50); 2) decreased cardiac arrhythmias (negative chronotropic and dromotropic effects) (6, 45, 46, 73, 123); 3) decreased platelet aggregation (7, 63, 97, 98); 4) increased myocardial glucose metabolism and energetics (8, 69, 71, 77, 102, 119, 120); 5) antioxidant effect (decreased superoxide production) (37, 127, 174); 6) reduced infarct size (preconditioning) (10, 124, 132, 192, 199); and 7) attenuation of myocardial stunning (171, 179, 210).

In summary, recent experimental evidence indicates that adenosine is not the physiological local metabolic vasodilatory metabolite that links coronary blood flow to myocardial metabolism. However, adenosine plays a significant role in increasing coronary blood flow and protecting the ischemic myocardium from irreversible damage.


   KATP CHANNELS
TOP
 ABSTRACT
 OXYGEN AND CARBON DIOXIDE
 ADENOSINE HYPOTHESIS
 KATP CHANNELS
NITRIC OXIDE
 PROSTAGLANDINS
 ENDOTHELIUM-DERIVED...
 ENDOTHELIN
 MULTIPLE CONTROLLERS
 SYMPATHETIC CONTROL OF CORONARY...
 {beta}-ADRENOCEPTOR-MEDIATED...
 {alpha}-ADRENOCEPTOR-MEDIATED...
 CONCLUSION
 GRANTS
 REFERENCES
 
ATP-dependent K+ (KATP) channels were first identified in 1983 by Noma (158). These channels are present in a variety of tissues including vascular smooth muscle, arterial endothelial cells, cardiac muscle, skeletal muscle, brain, and pancreatic {beta}-cells (9, 35, 107, 144, 153, 158, 182). KATP channels are activated by alterations in the cellular metabolic state which, in turn, initiate membrane hyperpolarization and relaxation of vascular smooth muscle (153).

Interestingly, KATP channels are involved in adenosine-mediated coronary vasodilation because the sulfonylurea derivative glibenclamide (KATP channel antagonist) significantly impairs adenosine-induced vasodilation (2, 18, 34, 40, 60, 93, 113, 154, 160, 183). Early investigations have shown that KATP channels play a role in hypoxia-induced coronary vasodilation (40, 151) and coronary reactive hyperemia (11, 34, 60). However, because hypoxia and ischemia result in adenosine release from the myocardium (see ADENOSINE HYPOTHESIS above), the blunting of hypoxic or ischemic coronary vasodilation by glibenclamide most likely represents inhibition of adenosine-mediated vasodilation (see MULTIPLE CONTROLLERS below).

Under normal baseline conditions, blockade of KATP channels with glibenclamide results in a decrease in coronary blood flow (12–25%) with little or no change in myocardial oxygen consumption (39, 58, 60, 72, 100, 137, 147, 172, 177, 183), demonstrating that KATP channels contribute to basal coronary vascular tone. In contrast, KATP channels are not required for local metabolic vasodilation during increases in myocardial oxygen consumption (55, 58–60, 137, 172, 173). Richmond et al. found that glibenclamide did not attenuate the increase in coronary blood flow to paired cardiac pacing (172) or treadmill exercise (173) in dogs. They found that the relationship between coronary venous PO2 and myocardial oxygen consumption was shifted downward in a parallel manner by glibenclamide (Fig. 3B), indicating that KATP channels exert a tonic coronary vasodilator influence at rest and during exercise. These results are consistent with other studies in dogs (58–60) and pigs (55, 137). Also, these channels do not appear to be required for maintaining coronary blood flow constant when coronary perfusion pressure is altered, i.e., pressure-flow autoregulation (183), although glibenclamide treatment slows the response to a step change in coronary perfusion pressure (39). Taken together, these findings demonstrate that KATP channels have a tonic resting vasodilator effect in the coronary circulation that is also present during exercise. The evidence for greater coronary KATP channel opening during exercise is inconsistent, indicating that other factors are important for local metabolic control when myocardial oxygen consumption is augmented.


   NITRIC OXIDE
TOP
 ABSTRACT
 OXYGEN AND CARBON DIOXIDE
 ADENOSINE HYPOTHESIS
 KATP CHANNELS
 NITRIC OXIDE
PROSTAGLANDINS
 ENDOTHELIUM-DERIVED...
 ENDOTHELIN
 MULTIPLE CONTROLLERS
 SYMPATHETIC CONTROL OF CORONARY...
 {beta}-ADRENOCEPTOR-MEDIATED...
 {alpha}-ADRENOCEPTOR-MEDIATED...
 CONCLUSION
 GRANTS
 REFERENCES
 
Nitric oxide is formed from L-arginine by nitric oxide synthase and is released by endothelial cells (146). Nitric oxide release is augmented by agonists such as acetylcholine and bradykinin (5, 146, 167) and also by mechanical stimulation such as shear stress (27, 28, 110, 114, 116, 184), pulsatile flow (30), and axial strain (12).

Nitric oxide has been implicated as a factor in matching coronary blood flow with changes in myocardial metabolism. However, inhibition of nitric oxide synthesis with arginine analogs results in little (66, 70, 126, 130, 155) or no change (4, 22, 30, 41, 53, 101, 162, 165, 180, 181, 196, 202) in coronary blood flow at rest or when myocardial oxygen consumption is elevated. Studies also consistently show that nitric oxide is not required for exercise-induced coronary vasodilation (4, 22, 53, 101, 180, 196, 202). However, nitric oxide synthesis inhibition does decrease coronary venous oxygen tension at a given level of myocardial oxygen consumption (4, 22, 53, 101, 180, 196, 202), indicating that nitric oxide exerts a tonic vasodilator influence at rest and during increases in myocardial metabolism (Fig. 3C). The primary vasodilatory effect of nitric oxide is probably located in large coronary arteries because numerous studies have demonstrated a significant reduction in epicardial coronary diameter when nitric oxide synthesis is inhibited at rest (32, 33, 87, 105, 122, 155, 163) and during increases in myocardial oxygen consumption (19, 30, 66, 70, 170, 202). Studies by Bernstein et al. (22) and Traverse et al. (195) indicate that the exercise-induced epicardial coronary vasodilation is mediated by an increase in endothelial-mediated nitric oxide production at high levels of myocardial oxygen consumption. This increased nitric oxide production is most likely due to augmented shear stress that results from the high coronary flow rates (27, 28, 110, 114, 116, 184, 201). The vasodilation of epicardial coronary arteries by nitric oxide is physiologically beneficial in that it acts to prevent excessive shear stress on coronary endothelial cells and to preserve arteriolar vasodilator reserve (106).


   PROSTAGLANDINS
TOP
 ABSTRACT
 OXYGEN AND CARBON DIOXIDE
 ADENOSINE HYPOTHESIS
 KATP CHANNELS
 NITRIC OXIDE
 PROSTAGLANDINS
ENDOTHELIUM-DERIVED...
 ENDOTHELIN
 MULTIPLE CONTROLLERS
 SYMPATHETIC CONTROL OF CORONARY...
 {beta}-ADRENOCEPTOR-MEDIATED...
 {alpha}-ADRENOCEPTOR-MEDIATED...
 CONCLUSION
 GRANTS
 REFERENCES
 
Prostaglandins are arachidonic acid metabolites that have been shown to be released into the coronary circulation during episodes of hypoxia (1), anoxia (23), and coronary artery occlusion (3). However, an important role of prostaglandins in physiological local metabolic coronary vasodilation has not been demonstrated (38, 65, 89, 96). Dai and Bache (38) found that inhibition of prostaglandins with indomethacin did not significantly affect resting coronary blood flow or attenuate exercise-induced coronary vasodilation. In addition, the relationship between coronary venous oxygen tension and myocardial oxygen consumption was unaltered by indomethacin (Fig. 3E), demonstrating that prostaglandins do not mediate functional coronary exercise hyperemia. These findings agree with the study of Edlund et al. (65), who found that ibuprofen did not significantly attenuate exercise hyperemia in normal, healthy humans. Prostaglandins may play a role in coronary blood flow control in patients with ischemic heart disease (52, 80). However, this is not a consistent finding (61, 161).


   ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR
TOP
 ABSTRACT
 OXYGEN AND CARBON DIOXIDE
 ADENOSINE HYPOTHESIS
 KATP CHANNELS
 NITRIC OXIDE
 PROSTAGLANDINS
 ENDOTHELIUM-DERIVED...
ENDOTHELIN
 MULTIPLE CONTROLLERS
 SYMPATHETIC CONTROL OF CORONARY...
 {beta}-ADRENOCEPTOR-MEDIATED...
 {alpha}-ADRENOCEPTOR-MEDIATED...
 CONCLUSION
 GRANTS
 REFERENCES
 
Endothelium-derived hyperpolarizing factor (EDHF) is released by coronary endothelial cells and mediates vasodilation by hyperpolarizing vascular smooth muscle (79, 156). The presence of EDHF is based on the observation that the endothelium-dependent vasodilator acetylcholine hyperpolarizes and relaxes isolated coronary vessels in the presence of combined nitric oxide and cyclooxygenase blockade (78, 79, 108, 166, 168, 189). It appears that a component of EDHF is cytochrome P-450 metabolites of arachidonic acid, i.e., epoxyeicosatrienoic acids and hydroxyeicosatetraenoic acids, both of which modulate coronary vascular tone (29, 78, 88, 141, 156, 157, 159, 175, 205). Although EDHF has been shown to mediate coronary vascular relaxation, its role in local metabolic coronary vasodilation during increases in myocardial metabolism has not been investigated.


   ENDOTHELIN
TOP
 ABSTRACT
 OXYGEN AND CARBON DIOXIDE
 ADENOSINE HYPOTHESIS
 KATP CHANNELS
 NITRIC OXIDE
 PROSTAGLANDINS
 ENDOTHELIUM-DERIVED...
 ENDOTHELIN
MULTIPLE CONTROLLERS
 SYMPATHETIC CONTROL OF CORONARY...
 {beta}-ADRENOCEPTOR-MEDIATED...
 {alpha}-ADRENOCEPTOR-MEDIATED...
 CONCLUSION
 GRANTS
 REFERENCES
 
Endothelin-1 is an endothelium-derived peptide that has potent, long-acting vasoconstrictor properties (207). The role of endothelin in the coronary circulation has recently been reviewed by Lavallee and Thorin (118). Endothelin-mediated coronary vasoconstriction occurs via activation of ETA receptors (83, 125, 140, 164, 191). However, endothelin can also exert a vasodilator influence on coronary arteries through activation of ETB receptors, but the net effect of endothelin is vasoconstriction. The sensitivity for endothelin-mediated coronary vasoconstriction increases with decreasing vessel diameter (103, 117). Recent investigations that have examined the effects of endothelin receptor blockade consistently show that endothelin contributes to coronary vascular tone under resting conditions but that endothelin has little or no effect on coronary blood flow control as myocardial oxygen consumption is increased during exercise (136, 138, 187). This finding is not surprising in light of the fact that arterial and coronary venous endothelin concentrations are unchanged with exercise (138, 187). Thus inhibition of endothelium-mediated vasoconstriction contributes little to exercise hyperemia.

Interestingly, studies from the Chilian laboratory indicate that {alpha}1-adrenoceptor stimulation of cardiac myocytes promotes endothelin-mediated coronary vasoconstriction both in vitro (193) and in vivo (42). However, at present this mechanism has only been demonstrated with intracoronary infusions of pharmacological concentrations of {alpha}1-adrenoceptor agonists. Whether this mechanism of {alpha}1-adrenoceptor-mediated endothelin release is active under physiological conditions such as exercise has not been determined.


   MULTIPLE CONTROLLERS
TOP
 ABSTRACT
 OXYGEN AND CARBON DIOXIDE
 ADENOSINE HYPOTHESIS
 KATP CHANNELS
 NITRIC OXIDE
 PROSTAGLANDINS
 ENDOTHELIUM-DERIVED...
 ENDOTHELIN
 MULTIPLE CONTROLLERS
SYMPATHETIC CONTROL OF CORONARY...
 {beta}-ADRENOCEPTOR-MEDIATED...
 {alpha}-ADRENOCEPTOR-MEDIATED...
 CONCLUSION
 GRANTS
 REFERENCES
 
There are multiple mechanisms of coronary blood flow control, and one hypothesis was that when KATP channels or nitric oxide synthesis are inhibited, adenosine levels increase in compensation. The reason for postulating adenosine compensation is based on the observation that the addition of an adenosine receptor antagonist after prior KATP channel blockade (59, 60, 101) or nitric oxide synthesis inhibition (130, 190) decreased coronary blood flow and/or depressed the slope of the relationship between coronary venous oxygen tension and myocardial oxygen consumption. However, recent studies from the Feigl laboratory have demonstrated that inhibition of either KATP channels or nitric oxide synthesis does not significantly increase coronary venous or estimated cardiac interstitial adenosine concentration at rest and during exercise (172, 173, 196). In addition, the estimated interstitial adenosine concentration remained well below the threshold necessary for coronary vasodilation with or without KATP channel blockade (172, 173) or nitric oxide synthesis inhibition (196). These findings indicate that adenosine does not increase in compensation when KATP channels or nitric oxide synthesis is inhibited during exercise.

A probable explanation for the discordant results is that the intracoronary glibenclamide infusions used by the Bache laboratory (59, 60, 101) result in myocardial ischemia, as demonstrated by decreased myocardial function (101). It is well recognized that ischemic myocardium releases adenosine, thus the adenosine effect is probably due to ischemia rather than a physiological compensatory effect. Similar intracoronary glibenclamide infusions have resulted in oscillations in coronary blood flow (150, 177). Although it has not been studied, a plausible mechanism for the coronary blood flow oscillations is that glibenclamide produces ischemia that increases adenosine levels and thus coronary flow, which relieves the ischemia and washes out the adenosine to return to ischemia in an oscillatory manner.

Combined blockade of adenosine receptors, KATP channels, and nitric oxide synthesis produces a marked parallel downward shift in the coronary venous oxygen tension vs. myocardial oxygen consumption graph (Fig. 3D) (197). This triple blockade resulted in coronary venous oxygen tensions below 7 Torr during exercise with an increase in coronary venous adenosine concentration. However, the adenosine levels did not increase sufficiently to overcome the adenosine receptor blockade. The interpretation is that triple blockade causes a decrease in resting coronary blood flow and that the added stress of exercise results in incipient subendocardial ischemia.

Another question is whether KATP channels and nitric oxide act on coronary blood flow in a linear additive or nonlinear synergistic manner (137). The data from pigs (137) and dogs shown in Fig. 3F suggest the effects are approximately additive.


   SYMPATHETIC CONTROL OF CORONARY BLOOD FLOW
TOP
 ABSTRACT
 OXYGEN AND CARBON DIOXIDE
 ADENOSINE HYPOTHESIS
 KATP CHANNELS
 NITRIC OXIDE
 PROSTAGLANDINS
 ENDOTHELIUM-DERIVED...
 ENDOTHELIN
 MULTIPLE CONTROLLERS
 SYMPATHETIC CONTROL OF CORONARY...
{beta}-ADRENOCEPTOR-MEDIATED...
 {alpha}-ADRENOCEPTOR-MEDIATED...
 CONCLUSION
 GRANTS
 REFERENCES
 
Sympathetic nervous system activation during exercise increases heart rate, cardiac contractility, and left ventricular afterload, all of which result in metabolic vasodilation. The local metabolic vasodilation obscures the direct effects of sympathetic stimulation on coronary blood vessels. These direct effects include both vasoconstriction through coronary {alpha}-adrenoceptors and vasodilation via {beta}-adrenoceptors.


   {beta}-ADRENOCEPTOR-MEDIATED FEEDFORWARD CORONARY VASODILATION
TOP
 ABSTRACT
 OXYGEN AND CARBON DIOXIDE
 ADENOSINE HYPOTHESIS
 KATP CHANNELS
 NITRIC OXIDE
 PROSTAGLANDINS
 ENDOTHELIUM-DERIVED...
 ENDOTHELIN
 MULTIPLE CONTROLLERS
 SYMPATHETIC CONTROL OF CORONARY...
 {beta}-ADRENOCEPTOR-MEDIATED...
{alpha}-ADRENOCEPTOR-MEDIATED...
 CONCLUSION
 GRANTS
 REFERENCES
 
Direct sympathetic vasodilation of the coronary vessels is an attractive hypothesis for matching coronary flow and oxygen consumption during exercise, because in this case the same stimulus responsible for increasing oxygen consumption will simultaneously increase oxygen delivery. Thus {beta}-adrenoceptor vasodilation is a "feedforward" mechanism that does not require an error signal such as decreased cellular oxygen tension (142, 143). The potential for coronary {beta}-adrenoceptor vasodilation can be seen most clearly in isolated blood vessels. Small coronary vessels dilate in response to epinephrine and norepinephrine, even without prior {alpha}-adrenoceptor blockade (169, 186, 209). Thus the net effect of sympathetic stimulation on coronary resistance vessels appears to be vasodilation. However, demonstration of {beta}-adrenoceptor coronary vasodilation during exercise is difficult because of the simultaneous presence of a large metabolic vasodilation. The key to separating these effects is to produce metabolic vasodilation free from direct vascular catecholamine effects. In conscious animals this has been achieved by exercise during simultaneous {alpha}- and {beta}-adrenoceptor blockade (56, 84). These responses are then compared with exercise during {alpha}-adrenoceptor blockade, a situation that includes both metabolic vasodilation and {beta}-adrenoceptor vasodilation. Thus the difference between these two conditions will reflect the influence of {beta}-adrenoceptor vasodilation. When coronary venous oxygen tension is plotted vs. myocardial oxygen consumption in these experiments (Fig. 4), it can be seen that venous oxygen tension is considerably lower at any given myocardial oxygen consumption when both {alpha}- and {beta}-adrenoceptors are blocked. The conclusion is that coronary arteriolar {beta}-receptors contribute substantially to exercise vasodilation.



View larger version (19K):
[in this window]
[in a new window]
  		Fig. 4. Coronary venous oxygen tension vs. myocardial oxygen consumption at rest and during exercise under control conditions, after {alpha}-adrenoceptor blockade, and after combined {alpha}- and {beta}-adrenoceptor blockade. A: individual data points and regression lines. B: regression lines and interpretation of the differences in slope. The large difference in slope between {alpha} and {alpha} + {beta} receptor blockade indicates a substantial feedforward {beta}-adrenoceptor component to exercise vasodilation. The difference between the control slope and the slope after {alpha}-adrenoceptor blockade demonstrates {alpha}-adrenoceptor-mediated vasoconstriction during exercise. [From Gorman et al. (84).]

 
The experimental approach above has one drawback. The presence of {alpha}-blockade increases neuronal catecholamine release, which may exaggerate feedforward {beta}-vasodilation. This problem has been addressed by estimating the vascular effects of the cardiac catecholamine concentrations measured during normal exercise without adrenergic blockade (85). Epinephrine is released by the adrenal glands and reaches the coronary circulation via the arterial plasma, so its effects can be approximated by exogenous epinephrine infusions in resting animals that match the arterial plasma concentrations during exercise. Plasma epinephrine concentrations reached during strenuous exercise increase myocardial oxygen consumption only slightly in resting dogs and do not change coronary sinus oxygen tension (85). Circulating epinephrine therefore contributes very little to feedforward sympathetic vasodilation.

The arterial plasma concentrations of norepinephrine are not very helpful, because the sympathetic nerves release norepinephrine directly into the interstitial space. It is the interstitial norepinephrine concentration to which the coronary arterioles are exposed. The interstitial norepinephrine concentration can be estimated when the arterial and coronary venous plasma concentrations, coronary plasma flow, and the coronary capillary permeability to norepinephrine are known (36). The interstitial concentration was estimated at 12 nM in strenuously exercising dogs (85). The effect of this concentration on arteriolar diameter was estimated from an in vitro norepinephrine dose-response curve (169). Assuming a cubic dependence of flow on arteriolar diameter (131), the exercise norepinephrine concentrations would increase coronary flow by ~67%. Because this level of exercise increased coronary blood flow by ~260%, feedforward {beta}-adrenoceptor vasodilation by norepinephrine can account for roughly 25% of coronary exercise hyperemia (85).


   {alpha}-ADRENOCEPTOR-MEDIATED FEEDFORWARD CORONARY VASOCONSTRICTION
TOP
 ABSTRACT
 OXYGEN AND CARBON DIOXIDE
 ADENOSINE HYPOTHESIS
 KATP CHANNELS
 NITRIC OXIDE
 PROSTAGLANDINS
 ENDOTHELIUM-DERIVED...
 ENDOTHELIN
 MULTIPLE CONTROLLERS
 SYMPATHETIC CONTROL OF CORONARY...
 {beta}-ADRENOCEPTOR-MEDIATED...
 {alpha}-ADRENOCEPTOR-MEDIATED...
CONCLUSION
 GRANTS
 REFERENCES
 
Coronary vessels also possess {alpha}-adrenoceptors capable of causing vasoconstriction during sympathetic activation. {alpha}-Adrenoceptor vasoconstriction can be demonstrated in two ways:

1) Coronary sympathetic nerve stimulation during {beta}-adrenoceptor blockade lowers coronary blood flow and coronary venous oxygen tension, and this effect can be blocked by {alpha}-adrenoceptor antagonists (67, 74, 75, 135, 152).

2) {alpha}-Adrenoceptor blockade during sympathetic stimulation or exercise results in higher coronary blood flow and coronary venous oxygen tension at a given level of myocardial oxygen consumption, compared with control conditions (14, 47, 86, 95, 99, 145, 149, 178). Interestingly, some of the increased coronary blood flow and coronary venous oxygen tension after {alpha}-adrenoceptor blockade during exercise is due to nitric oxide formation (188). The stimulus for increased nitric oxide formation in this case may be increased to-and-fro flow oscillations in the coronary arteries after {alpha}-adrenoceptor blockade (148).

The simultaneous presence of {alpha}-adrenoceptor vasoconstriction and {beta}-adrenoceptor vasodilation in the coronary circulation raises the question as to which one predominates during sympathetic activation. The answer depends on vessel size. Large coronary arteries in vitro contract in response to norepinephrine, whereas small coronary arteries relax under these conditions (169, 209). In vivo, {alpha}-adrenoceptor vasoconstriction is limited to vessels >100 µm in diameter (31). Because arterioles are the primary site of vascular resistance, the overall direct effect of sympathetic activity on coronary vessels is a decrease in vascular resistance. It should be noted that even large coronary arteries dilate in response to exercise. {alpha}-Adrenoceptor vasoconstriction limits the extent of this dilation rather than causing an actual reduction in diameter. Even so, {alpha}-adrenoceptor vasoconstriction in larger vessels may not be in direct competition with {beta}-adrenoceptor vasodilation. During strenuous exercise, the vasodilated subendocardium is vulnerable to underperfusion due to high myocardial compressive forces and short diastoles. {alpha}-Adrenoceptor vasoconstriction increases subendocardial flow under these conditions (99). The postulated mechanism is that {alpha}-adrenoceptor vasoconstriction increases vascular stiffness and so decreases capacitance in medium-sized intramyocardial vessels. The result is a reduction in wasteful to-and-fro flow oscillations during the cardiac cycle (148).

In summary, sympathetic activation results in feedforward {beta}-adrenoceptor-mediated coronary vasodilation in arterioles that helps match oxygen delivery to myocardial oxygen consumption during exercise. There is also a simultaneous {alpha}-adrenoceptor-mediated vasoconstrictor effect in medium and large coronary arteries that helps maintain subendocardial blood flow during exercise when there is tachycardia, augmented contractility, and high myocardial oxygen consumption.


   CONCLUSION
TOP
 ABSTRACT
 OXYGEN AND CARBON DIOXIDE
 ADENOSINE HYPOTHESIS
 KATP CHANNELS
 NITRIC OXIDE
 PROSTAGLANDINS
 ENDOTHELIUM-DERIVED...
 ENDOTHELIN
 MULTIPLE CONTROLLERS
 SYMPATHETIC CONTROL OF CORONARY...
 {beta}-ADRENOCEPTOR-MEDIATED...
 {alpha}-ADRENOCEPTOR-MEDIATED...
 CONCLUSION
GRANTS
 REFERENCES
 
The physiological local metabolic controller of coronary blood flow remains unknown. The use of a graph of coronary venous oxygen tension vs. myocardial oxygen consumption permits a critical analysis of the factors that control coronary blood flow when myocardial oxygen consumption is augmented, as during exercise. With this approach, the following conclusions may be drawn.

Numerous studies over the past four decades consistently demonstrate that adenosine acts as a pathophysiological coronary vasodilator when the myocardium becomes hypoxic or ischemic. Recent investigations reveal that adenosine acts as a cardioprotective agent during ischemia, producing preconditioning and ameliorating cardiac stunning. However, adenosine does not cause the physiological coronary vasodilation observed during exercise.

KATP channels contribute a vasodilator influence to resting coronary blood flow but are probably not responsible for local metabolic control during exercise.

Nitric oxide dilates large coronary arteries owing to the shear forces on endothelial cells but does not act as the local metabolic vasodilator during exercise.

The actions of adenosine, KATP channels, and nitric oxide are approximately additive, without one compensating for the other when it is blocked. In particular, in the absence of ischemia adenosine levels do not increase in compensation when KATP channels and nitric oxide synthesis are blocked.

Indomethacin treatment to block prostaglandin synthesis has little effect on coronary blood flow control.

Endothelin contributes a modest resting vasoconstrictor influence on the coronary circulation, but inhibition of endothelin is not the vasodilator mechanism in exercise hyperemia.

{beta}-Adrenoceptor-mediated feedforward dilation of coronary microvessels contributes ~25% to the increased coronary flow observed during exercise.

A paradoxical {alpha}-adrenoceptor-mediated vasoconstrictor effect in large- and medium-sized coronary arteries during exercise helps prevent subendocardial underperfusion when myocardial oxygen consumption, cardiac contractility, and heart rate are high.

Encouraging progress has been made in understanding the many factors that control coronary blood flow, but much remains to be done.


   GRANTS
TOP
 ABSTRACT
 OXYGEN AND CARBON DIOXIDE
 ADENOSINE HYPOTHESIS
 KATP CHANNELS
 NITRIC OXIDE
 PROSTAGLANDINS
 ENDOTHELIUM-DERIVED...
 ENDOTHELIN
 MULTIPLE CONTROLLERS
 SYMPATHETIC CONTROL OF CORONARY...
 {beta}-ADRENOCEPTOR-MEDIATED...
 {alpha}-ADRENOCEPTOR-MEDIATED...
 CONCLUSION
 GRANTS
REFERENCES
 
The authors were supported by National Heart, Lung, and Blood Institute Grants HL-49822 and HL-07403 (E. O. Feigl and M. W. Gorman) and HL-67804 (J. D. Tune) and by an American Diabetes Association Career Development Award (J. D. Tune).


   FOOTNOTES
 

Address for reprint requests and other correspondence: E. O. Feigl, Dept. of Physiology and Biophysics, Univ. of Washington School of Medicine, Box 357290, Seattle, WA 98195-7290 (E-mail: efeigl{at}u.washington.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 OXYGEN AND CARBON DIOXIDE
 ADENOSINE HYPOTHESIS
 KATP CHANNELS
 NITRIC OXIDE
 PROSTAGLANDINS
 ENDOTHELIUM-DERIVED...
 ENDOTHELIN
 MULTIPLE CONTROLLERS
 SYMPATHETIC CONTROL OF CORONARY...
 {beta}-ADRENOCEPTOR-MEDIATED...
 {alpha}-ADRENOCEPTOR-MEDIATED...
 CONCLUSION
 GRANTS
 REFERENCES
 

  1. Afonso S, Bandow GT, and Rowe GG. Indomethacin and the prostaglandin hypothesis of coronary blood flow regulation. J Physiol 241: 299–308, 1974.[Abstract/Free Full Text]
  2. Akatsuka Y, Egashira K, Katsuda Y, Narishige T, Ueno H, Shimokawa H, and Takeshita A. ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog. Cardiovasc Res 28: 906–911, 1994.[Abstract/Free Full Text]
  3. Alexander RW, Kent KM, Pisano JJ, Keiser HR, and Cooper T. Regulation of postocclusive hyperemia by endogenously synthesized prostaglandins in the dog heart. J Clin Invest 55: 1174–1181, 1975.[Web of Science][Medline]
  4. Altman JD, Kinn J, Duncker DJ, and Bache RJ. Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dog. Cardiovasc Res 28: 119–124, 1994.[Abstract/Free Full Text]
  5. Amezcua JL, Palmer RMJ, de Souza BM, and Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol 97: 1119–1124, 1989.[Web of Science][Medline]
  6. Amoah-Apraku B, Xu J, Lu JY, Pelleg A, Bruns RF, and Belardinelli L. Selective potentiation by an A1 adenosine receptor enhancer of the negative dromotropic action of adenosine in the guinea pig heart. J Pharmacol Exp Ther 266: 611–617, 1993.[Abstract/Free Full Text]
  7. Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F, Balbo A, and Trovati M. Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. Thromb Res 105: 71–78, 2002.[CrossRef][Web of Science][Medline]
  8. Angello DA, Berne RM, and Coddington NM. Adenosine and insulin mediate glucose uptake in normoxic rat hearts by different mechanisms. Am J Physiol Heart Circ Physiol 265: H880–H885, 1993.[Abstract/Free Full Text]
  9. Ashcroft SJ and Ashcroft FM. Properties and functions of ATP-sensitive K-channels. Cell Signal 2: 197–214, 1990.[CrossRef][Web of Science][Medline]
  10. Auchampach JA and Gross GJ. Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. Am J Physiol Heart Circ Physiol 264: H1327–H1336, 1993.[Abstract/Free Full Text]
  11. Aversano T, Ouyang P, and Silverman H. Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation. Circ Res 69: 618–622, 1991.[Abstract/Free Full Text]
  12. Awolesi MA, Sessa WC, and Sumpio BE. Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J Clin Invest 96: 1449–1454, 1995.[Web of Science][Medline]
  13. Bacchus AN, Ely SW, Knabb RM, Rubio R, and Berne RM. Adenosine and coronary blood flow in conscious dogs during normal physiological stimuli. Am J Physiol Heart Circ Physiol 243: H628–H633, 1982.[Abstract/Free Full Text]
  14. Bache RJ, Dai XZ, Herzog CA, and Schwartz JS. Effects of nonselective and selective {alpha}1-adrenergic blockade on coronary blood flow during exercise. Circ Res 61: II36–II41, 1987.[Medline]
  15. Bache RJ, Dai XZ, Schwartz JS, and Homans DC. Role of adenosine in coronary vasodilation during exercise. Circ Res 62: 846–853, 1988.[Abstract/Free Full Text]
  16. Bassingthwaighte JB. Interstitial adenosine: the measurement, the interpretation. J Mol Cell Cardiol 24: 337–346, 1992.[CrossRef][Web of Science][Medline]
  17. Belardinelli L, Linden J, and Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis 32: 73–97, 1989.[CrossRef][Web of Science][Medline]
  18. Belloni FL and Hintze TH. Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilation. Am J Physiol Heart Circ Physiol 261: H720–H727, 1991.[Abstract/Free Full Text]
  19. Berdeaux A, Ghaleh B, Dubois-Randé JL, Vigué B, la Rochelle CD, Hittinger L, and Giudicelli JF. Role of vascular endothelium in exercise-induced dilation of large epicardial coronary arteries in conscious dogs. Circulation 89: 2799–2808, 1994.[Abstract/Free Full Text]
  20. Berne RM. Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 204: 317–322, 1963.[Abstract/Free Full Text]
  21. Berne RM. The role of adenosine in the regulation of coronary blood flow. Circ Res 47: 807–813, 1980.[Free Full Text]
  22. Bernstein RD, Ochoa FY, Xu X, Forfia P, Shen W, Thompson CI, and Hintze TH. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res 79: 840–848, 1996.[Abstract/Free Full Text]
  23. Block AJ, Poole S, and Vane JR. Modification of basal release of prostaglandins from rabbit isolated hearts. Prostaglandins 7: 473–486, 1974.[CrossRef][Web of Science][Medline]
  24. Broten TP and Feigl EO. Role of myocardial oxygen and carbon dioxide in coronary autoregulation. Am J Physiol Heart Circ Physiol 262: H1231–H1237, 1992.[Abstract/Free Full Text]
  25. Broten TP, Romson JL, Fullerton DA, Van Winkle DM, and Feigl EO. Synergistic action of myocardial oxygen and carbon dioxide in controlling coronary blood flow. Circ Res 68: 531–542, 1991.[Abstract/Free Full Text]
  26. Bruckner R, Fenner A, Meyer W, Nobis TM, Schmitz W, and Scholz H. Cardiac effects of adenosine and adenosine analogs in guinea-pig atrial and ventricular preparations: evidence against a role of cyclic AMP and cyclic GMP. J Pharmacol Exp Ther 234: 766–774, 1985.[Abstract/Free Full Text]
  27. Buga GM, Gold ME, Fukuto JM, and Ignarro LJ. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 17: 187–193, 1991.[Abstract/Free Full Text]
  28. Busse R, Pohl U, and Luckhoff A. Mechanisms controlling the production of endothelial autacoids. Z Kardiol 78, Suppl 6: 64–69, 1989.
  29. Campbell WB, Gebremedhin D, Pratt PF, and Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415–423, 1996.[Abstract/Free Full Text]
  30. Canty JM and Schwartz JS. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation 89: 375–384, 1994.[Abstract/Free Full Text]
  31. Chilian WM, Layne SM, Eastham CL, and Marcus ML. Heterogeneous microvascular coronary {alpha}-adrenergic vasoconstriction. Circ Res 64: 376–388, 1989.[Abstract/Free Full Text]
  32. Chu A, Chambers DE, Lin CC, Kuehl WD, and Cobb FR. Nitric oxide modulates epicardial coronary basal vasomotor tone in awake dogs. Am J Physiol Heart Circ Physiol 258: H1250–H1254, 1990.[Abstract/Free Full Text]
  33. Chu A, Chambers DE, Lin CC, Kuehl WD, Palmer RMJ, Moncada S, and Cobb FR. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest 87: 1964–1968, 1991.[Web of Science][Medline]
  34. Clayton FC, Hess TA, Smith MA, and Grover GJ. Coronary reactive hyperemia and adenosine-induced vasodilation are mediated partially by a glyburide-sensitive mechanism. Pharmacology 44: 92–100, 1992.[Web of Science][Medline]
  35. Cook DL and Hales CN. Intracellular ATP directly blocks K+ channels in pancreatic B-cells. Nature 311: 271–273, 1984.[CrossRef][Medline]
  36. Cousineau D, Goresky CA, Bach GG, and Rose CP. Effect of {beta}-adrenergic blockade on in vivo norepinephrine release in canine heart. Am J Physiol Heart Circ Physiol 246: H283–H292, 1984.[Abstract/Free Full Text]
  37. Cronstein BN, Kramer SB, Weissmann G, and Hirschhorn R. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 158: 1160–1177, 1983.[Abstract/Free Full Text]
  38. Dai XZ and Bache RJ. Effect of indomethacin on coronary blood flow during graded treadmill exercise in the dog. Am J Physiol Heart Circ Physiol 247: H452–H458, 1984.[Abstract/Free Full Text]
  39. Dankelman J, Van der Ploeg CPB, and Spaan JAE. Glibenclamide decelerates the responses of coronary regulation in the goat. Am J Physiol Heart Circ Physiol 266: H1715–H1721, 1994.[Abstract/Free Full Text]
  40. Daut J, Maier-Rudolph W, von Beckerath N, Mehrke G, Günther K, and Goedel-Meinen L. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 247: 1341–1344, 1990.[Abstract/Free Full Text]
  41. Davis CAI, Sherman AJ, Yaroshenko Y, Harris KR, Hedjbeli S, Parker MA, and Klocke FJ. Coronary vascular responsiveness to adenosine is impaired additively by blockade of nitric oxide synthesis and a sulfonylurea. J Am Coll Cardiol 31: 816–822, 1998.[Abstract/Free Full Text]
  42. DeFily DV, Nishikawa Y, and Chilian WM. Endothelin antagonists block {alpha}1-adrenergic constriction of coronary arterioles. Am J Physiol Heart Circ Physiol 276: H1028–H1034, 1999.[Abstract/Free Full Text]
  43. Degubareff T and Sleator W Jr. Effects of caffeine on mammalian atrial muscle, and its interaction with adenosine and calcium. J Pharmacol Exp Ther 148: 202–214, 1965.[Abstract/Free Full Text]
  44. Deussen A and Schrader J. Cardiac adenosine production is linked to myocardial pO2. J Mol Cell Cardiol 23: 495–504, 1991.[CrossRef][Web of Science][Medline]
  45. DiMarco JP, Sellers TD, Berne RM, West GA, and Belardinelli L. Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation 68: 1254–1263, 1983.[Abstract/Free Full Text]
  46. DiMarco JP, Sellers TD, Lerman BB, Greenberg ML, Berne RM, and Belardinelli L. Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol 6: 417–425, 1985.[Abstract]
  47. DiSalvo J, Parker PE, Scott JB, and Haddy FJ. Carotid baroceptor influence on coronary vascular resistance in the anesthetized dog. Am J Physiol 221: 156–160, 1971.[Free Full Text]
  48. Dobson JG Jr. Mechanism of adenosine inhibition of catecholamine-induced responses in heart. Circ Res 52: 151–160, 1983.[Abstract/Free Full Text]
  49. Dobson JG Jr, Ordway RW, and Fenton RA. Endogenous adenosine inhibits catecholamine contractile responses in normoxic hearts. Am J Physiol Heart Circ Physiol 251: H455–H462, 1986.[Abstract/Free Full Text]
  50. Dobson JG Jr and Schrader J. Role of extracellular and intracellular adenosine in the attenuation of catecholamine evoked responses in guinea pig heart. J Mol Cell Cardiol 16: 813–822, 1984.[CrossRef][Web of Science][Medline]
  51. Downey HF, Merrill GF, Yonekura S, Watanabe N, and Jones CE. Adenosine deaminase attenuates norepinephrine-induced coronary functional hyperemia. Am J Physiol Heart Circ Physiol 254: H417–H424, 1988.[Abstract/Free Full Text]
  52. Duffy SJ, Castle SF, Harper RW, and Meredith IT. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation. Circulation 100: 1951–1957, 1999.[Abstract/Free Full Text]
  53. Duncker DJ and Bache RJ. Inhibition of nitric oxide production aggravates myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis. Circ Res 74: 629–640, 1994.[Abstract/Free Full Text]
  54. Duncker DJ, Laxson DD, Lindstrom P, and Bache RJ. Endogenous adenosine and coronary vasoconstriction in hypoperfused myocardium during exercise. Cardiovasc Res 27: 1592–1597, 1993.[Abstract/Free Full Text]
  55. Duncker DJ, Oei HH, Hu F, Stubenitsky R, and Verdouw PD. Role of KATP+ channels in regulation of systemic, pulmonary, and coronary vasomotor tone in exercising swine. Am J Physiol Heart Circ Physiol 280: H22–H33, 2001.[Abstract/Free Full Text]
  56. Duncker DJ, Stubenitsky R, and Verdouw PD. Autonomic control of vasomotion in the porcine coronary circulation during treadmill exercise: evidence for feed-forward {beta}-adrenergic control. Circ Res 82: 1312–1322, 1998.[Abstract/Free Full Text]
  57. Duncker DJ, Stubenitsky R, and Verdouw PD. Role of adenosine in the regulation of coronary blood flow in swine at rest and during treadmill exercise. Am J Physiol Heart Circ Physiol 275: H1663–H1672, 1998.[Abstract/Free Full Text]
  58. Duncker DJ, Van Zon NS, Altman JD, Pavek TJ, and Bache RJ. Role of K+ATP channels in coronary vasodilation during exercise. Circulation 88: 1245–1253, 1993.[Abstract/Free Full Text]
  59. Duncker DJ, Van Zon NS, Ishibashi Y, and Bache RJ. Role of K+ATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow. J Clin Invest 97: 996–1009, 1996.[Web of Science][Medline]
  60. Duncker DJ, Van Zon NS, Pavek TJ, Herrlinger SK, and Bache RJ. Endogenous adenosine mediates coronary vasodilation during exercise after K+ATP channel blockade. J Clin Invest 95: 285–295, 1995.[Web of Science][Medline]
  61. Edlund A, Berglund B, van Dorne D, Kaijser L, Nowak J, Patrono C, Sollevi A, and Wennmalm A. Coronary flow regulation in patients with ischemic heart disease: release of purines and prostacyclin and the effect of inhibitors of prostaglandin formation. Circulation 71: 1113–1120, 1985.[Abstract/Free Full Text]
  62. Edlund A, Conradsson T, and Sollevi A. A role for adenosine in coronary vasoregulation in man. Effects of theophylline and enprofylline. Clin Physiol 15: 623–636, 1995.[Web of Science][Medline]
  63. Edlund A, Siden A, and Sollevi A. Evidence for an anti-aggregatory effect of adenosine at physiological concentrations and for its role in the action of dipyridamole. Thromb Res 45: 183–190, 1987.[CrossRef][Web of Science][Medline]
  64. Edlund A and Sollevi A. Theophylline increases coronary vascular tone in humans: evidence for a role of endogenous adenosine in flow regulation. Acta Physiol Scand 155: 303–311, 1995.[Web of Science][Medline]
  65. Edlund A, Sollevi A and Wennmalm . The role of adenosine and prostacyclin in coronary flow regulation in healthy man. Acta Physiol Scand 135: 39–46, 1989.[Web of Science][Medline]
  66. Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Kubota T, Hirakawa Y, and Takeshita A. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. Circ Res 79: 331–335, 1996.[Abstract/Free Full Text]
  67. Ek L and blad B. Effects of three beta adrenergic receptor blockers on myocardial oxygen consumption in the dog. Eur J Pharmacol 14: 19–28, 1971.[CrossRef][Web of Science][Medline]
  68. Ely SW, Knabb RM, Bacchus AN, Rubio R, and Berne RM. Measurements of coronary plasma and pericardial infusate adenosine concentrations during exercise in conscious dog: relationship to myocardial oxygen consumption and coronary blood flow. J Mol Cell Cardiol 15: 673–683, 1983.[CrossRef][Web of Science][Medline]
  69. Ely SW, Mentzer RM Jr, Lasley RD, Lee BK, and Berne RM. Functional and metabolic evidence of enhanced myocardial tolerance to ischemia and reperfusion with adenosine. J Thorac Cardiovasc Surg 90: 549–556, 1985.[Abstract]
  70. Embrey RP, Brooks LA, and Dellsperger KC. Mechanism of coronary microvascular responses to metabolic stimulation. Cardiovasc Res 35: 148–157, 1997.[Abstract/Free Full Text]
  71. Fang HK, Sturgeon C, Segil LJ, Ripper RL, and Law WR. Cardiac contractile function during coronary stenosis in dogs: association of adenosine in glycolytic dependence. Am J Physiol Heart Circ Physiol 272: H2195–H2203, 1997.[Abstract/Free Full Text]
  72. Farouque HM, Worthley SG, Meredith IT, Skyrme-Jones RA, and Zhang MJ. Effect of ATP-sensitive potassium channel inhibition on resting coronary vascular responses in humans. Circ Res 90: 231–236, 2002.[Abstract/Free Full Text]
  73. Favale S, Di Biase M, Rizzo U, Belardinelli L, and Rizzon P. Effect of adenosine and adenosine-5'-triphosphate on atrioventricular conduction in patients. J Am Coll Cardiol 5: 1212–1219, 1985.[Abstract]
  74. Feigl EO. Sympathetic control of coronary circulation. Circ Res 20: 262–271, 1967.[Abstract/Free Full Text]
  75. Feigl EO. Control of myocardial oxygen tension by sympathetic coronary vasoconstriction in the dog. Circ Res 37: 88–95, 1975.[Abstract/Free Full Text]
  76. Feigl EO. Coronary physiology. Physiol Rev 63: 1–205, 1983.[Abstract/Free Full Text]
  77. Finegan BA, Lopaschuk GD, Coulson CS, and Clanachan AS. Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts. Circulation 87: 900–908, 1993.[Abstract/Free Full Text]
  78. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, and Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401: 493–497, 1999.[CrossRef][Medline]
  79. Fleming I, Bauersachs J, and Busse R. Paracrine functions of the coronary vascular endothelium. Mol Cell Biochem 157: 137–145, 1996.[Web of Science][Medline]
  80. Friedman PL, Brown EJ Jr, Gunther S, Alexander RW, Barry WH, Mudge GH Jr, and Grossman W. Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease. N Engl J Med 305: 1171–1175, 1981.[Abstract]
  81. Gerlach E, Deuticke B, and Dreisbach RH. Der Nucleotid-Abbau im Herzmuskel bei Sauerstoffmangel und seine mögliche Bedeutung für die Coronardurchblutung. Naturwissenschaften 50: 228–229, 1963.[CrossRef][Web of Science]
  82. Gidday JM, Hill HE, Rubio R, and Berne RM. Estimates of left ventricular interstitial fluid adenosine during catecholamine stimulation. Am J Physiol Heart Circ Physiol 254: H207–H216, 1988.[Abstract/Free Full Text]
  83. Godfraind T. Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br J Pharmacol 110: 1201–1205, 1993.[Web of Science][Medline]
  84. Gorman MW, Tune JD, Richmond KN, and Feigl EO. Feedforward sympathetic coronary vasodilation in exercising dogs. J Appl Physiol 89: 1892–1902, 2000.[Abstract/Free Full Text]
  85. Gorman MW, Tune JD, Richmond KN, and Feigl EO. Quantitative analysis of feedforward sympathetic coronary vasodilation in exercising dogs. J Appl Physiol 89: 1903–1911, 2000.[Abstract/Free Full Text]
  86. Gwirtz PA and Stone HL. Coronary blood flow and myocardial oxygen consumption after alpha adrenergic blockade during submaximal exercise. J Pharmacol Exp Ther 217: 92–98, 1981.[Abstract/Free Full Text]
  87. Hamdad N, Ming Z, Parent R, and Lavallée M. {beta}2-Adrenergic dilation of conductance coronary arteries involves flow-dependent NO formation in conscious dogs. Am J Physiol Heart Circ Physiol 271: H1926–H1937, 1996.[Abstract/Free Full Text]
  88. Harder DR, Campbell WB, and Roman RJ. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res 32: 79–92, 1995.[Web of Science][Medline]
  89. Harlan DM, Rooke TW, Belloni FL, and Sparks HV. Effect of indomethacin on coronary vascular response to increased myocardial oxygen consumption. Am J Physiol Heart Circ Physiol 235: H372–H378, 1978.[Abstract/Free Full Text]
  90. Hart BJ, Bian X, Gwirtz PA, Setty S, and Downey HF. Right ventricular oxygen supply/demand balance in exercising dogs. Am J Physiol Heart Circ Physiol 281: H823–H830, 2001.[Abstract/Free Full Text]
  91. Headrick JP, Ely SW, Matherne GP, and Berne RM. Myocardial adenosine, flow, and metabolism during adenosine antagonism and adrenergic stimulation. Am J Physiol Heart Circ Physiol 264: H61–H70, 1993.[Abstract/Free Full Text]
  92. Headrick JP, Hack B, and Ashton KJ. Acute adenosinergic cardioprotection in ischemic-reperfused hearts. Am J Physiol Heart Circ Physiol 285: H1797–H1818, 2003.[Abstract/Free Full Text]
  93. Hein TW, Wang W, Zoghi B, Muthuchamy M, and Kuo L. Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine. J Mol Cell Cardiol 33: 271–282, 2001.[CrossRef][Web of Science][Medline]
  94. Heller LJ, Dole WP, and Mohrman DE. Adenosine receptor blockade enhances isoproterenol-induced increases in cardiac interstitial adenosine. J Mol Cell Cardiol 23: 887–898, 1991.[CrossRef][Web of Science][Medline]
  95. Heyndrickx GR, Muylaert P, and Pannier JL. {alpha}-Adrenergic control of oxygen delivery to myocardium during exercise in conscious dogs. Am J Physiol Heart Circ Physiol 242: H805–H809, 1982.[Abstract/Free Full Text]
  96. Hintze TH and Kaley G. Prostaglandins and the control of blood flow in the canine myocardium. Circ Res 40: 313–320, 1977.[Abstract/Free Full Text]
  97. Hourani SM. Purinoceptors and platelet aggregation. J Auton Pharmacol 16: 349–352, 1996.[Web of Science][Medline]
  98. Hourani SM and Cusack NJ. Pharmacological receptors on blood platelets. Pharmacol Rev 43: 243–298, 1991.[Web of Science][Medline]
  99. Huang AH and Feigl EO. Adrenergic coronary vasoconstriction helps maintain uniform transmural blood flow distribution during exercise. Circ Res 62: 286–298, 1988.[Abstract/Free Full Text]
  100. Imamura Y, Tomoike H, Narishige T, Takahashi T, Kasuya H, and Takeshita A. Glibenclamide decreases basal coronary blood flow in anesthetized dogs. Am J Physiol Heart Circ Physiol 263: H399–H404, 1992.[Abstract/Free Full Text]
  101. Ishibashi Y, Duncker DJ, Zhang J, and Bache RJ. ATP-sensitive K+ channels, adenosine, and nitric oxide- mediated mechanisms account for coronary vasodilation during exercise. Circ Res 82: 346–359, 1998.[Abstract/Free Full Text]
  102. Jesmok GJ, Gross GJ, and Hardman HF. The effect of adenosine on myocardial metabolism and oxygen consumption in the isolated dog heart preparation. J Mol Cell Cardiol 10: 249–261, 1978.[CrossRef][Web of Science][Medline]
  103. Jones AW, Rubin LJ, and Magliola L. Endothelin-1 sensitivity of porcine coronary arteries is reduced by exercise training and is gender dependent. J Appl Physiol 87: 1172–1177, 1999.[Abstract/Free Full Text]
  104. Jones CE, Hurst TW, and Randall JR. Effect of aminophylline on coronary functional hyperemia and myocardial adenosine. Am J Physiol Heart Circ Physiol 243: H480–H487, 1982.[Abstract/Free Full Text]
  105. Jones CJH, DeFily DV, Patterson JL, and Chilian WM. Endothelium-dependent relaxation competes with {alpha}1- and {alpha}2-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation 87: 1264–1274, 1993.[Abstract/Free Full Text]
  106. Jones CJH, Kuo L, Davis MJ, and Chilian WM. Regulation of coronary blood flow: coordination of heterogeneous control mechanisms in vascular microdomains. Cardiovasc Res 29: 585–596, 1995.[CrossRef][Web of Science][Medline]
  107. Katnik C and Adams DJ. Characterization of ATP-sensitive potassium channels in freshly dissociated rabbit aortic endothelial cells. Am J Physiol Heart Circ Physiol 272: H2507–H2511, 1997.[Abstract/Free Full Text]
  108. Kauser K and Rubanyi GM. Bradykinin-induced, N omega-nitro-L-arginine-insensitive endothelium-dependent relaxation of porcine coronary arteries is not mediated by bioassayable relaxing substances. J Cardiovasc Pharmacol 20, Suppl 12: S101–S104, 1992.
  109. Knabb RM, Ely SW, Bacchus AN, Rubio R, and Berne RM. Consistent parallel relationships among myocardial oxygen consumption, coronary blood flow, and pericardial infusate adenosine concentration with various interventions and {beta}-blockade in the dog. Circ Res 53: 33–41, 1983.[Abstract/Free Full Text]
  110. Koller A, Sun D, and Kaley G. Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro. Circ Res 72: 1276–1284, 1993.[Abstract/Free Full Text]
  111. Kroll K and Feigl EO. Adenosine is unimportant in controlling coronary blood flow in unstressed dog hearts. Am J Physiol Heart Circ Physiol 249: H1176–H1187, 1985.[Abstract/Free Full Text]
  112. Kroll K and Stepp DW. Adenosine kinetics in the canine coronary circulation. Am J Physiol Heart Circ Physiol 270: H1469–H1483, 1996.[Abstract/Free Full Text]
  113. Kuo L and Chancellor JD. Adenosine potentiates flow-induced dilation of coronary arterioles by activating KATP channels in endothelium. Am J Physiol Heart Circ Physiol 269: H541–H549, 1995.[Abstract/Free Full Text]
  114. Kuo L, Davis MJ, and Chilian WM. Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol Heart Circ Physiol 259: H1063–H1070, 1990.[Abstract/Free Full Text]
  115. Kusachi S and Olsson RA. Pericardial superfusion to measure cardiac interstitial adenosine concentration. Am J Physiol Heart Circ Physiol 244: H458–H461, 1983.[Abstract/Free Full Text]
  116. Lamontagne D, Pohl U, and Busse R. Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res 70: 123–130, 1992.[Abstract/Free Full Text]
  117. Laughlin MH and Muller JM. Vasoconstrictor responses of coronary resistance arteries in exercise-trained pigs. J Appl Physiol 84: 884–889, 1998.[Abstract/Free Full Text]
  118. Lavallee M and Thorin E. Role of ET-1 in the regulation of coronary circulation. Can J Physiol Pharmacol 81: 570–577, 2003.[CrossRef][Web of Science][Medline]
  119. Law WR, McLane MP, and Raymond RM. Adenosine is required for myocardial insulin responsiveness in vivo. Diabetes 37: 842–845, 1988.[Abstract]
  120. Law WR and Raymond RM. Adenosine potentiates insulin-stimulated myocardial glucose uptake in vivo. Am J Physiol Heart Circ Physiol 254: H970–H975, 1988.[Abstract/Free Full Text]
  121. Laxson DD, Homans DC, and Bache RJ. Inhibition of adenosine-mediated coronary vasodilation exacerbates myocardial ischemia during exercise. Am J Physiol Heart Circ Physiol 265: H1471–H1477, 1993.[Abstract/Free Full Text]
  122. Lefroy DC, Crake T, Uren NG, Davies GJ, and Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 88: 43–54, 1993.[Abstract/Free Full Text]
  123. Lerman BB and Belardinelli L. Effect of adenosine on ventricular tachycardia. Prog Clin Biol Res 230: 301–314, 1987.[Medline]
  124. Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA, and Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84: 350–356, 1991.[Abstract/Free Full Text]
  125. MacCarthy PA, Pegge NC, Pendergast BD, Shah AM, and Groves PH. The physiological role of endogenous endothelin in the regulation of human coronary vasomotor tone. J Am Coll Cardiol 37: 137–143, 2001.[Abstract/Free Full Text]
  126. Maekawa K, Saito D, Obayashi N, Uchida S, and Haraoka S. Role of endothelium-derived nitric oxide and adenosine in functional myocardial hyperemia. Am J Physiol Heart Circ Physiol 267: H166–H173, 1994.[Abstract/Free Full Text]
  127. Maggirwar SB, Dhanraj DN, Somani SM, and Ramkumar V. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun 201: 508–515, 1994.[CrossRef][Web of Science][Medline]
  128. Mallet RT, Lee SC, and Downey HF. Endogenous adenosine increases O2 utilization efficiency in isoprenaline-stimulated canine myocardium. Cardiovasc Res 31: 102–116, 1996.[CrossRef][Web of Science][Medline]
  129. Manfredi JP and Sparks HV Jr. Adenosine's role in coronary vasodilation induced by atrial pacing and norepinephrine. Am J Physiol Heart Circ Physiol 243: H536–H545, 1982.[Abstract/Free Full Text]
  130. Matsunaga T, Okumura K, Tsunoda R, Tayama S, Tabuchi T, and Yasue H. Role of adenosine in regulation of coronary flow in dogs with inhibited synthesis of endothelium-derived nitric oxide. Am J Physiol Heart Circ Physiol 270: H427–H434, 1996.[Abstract/Free Full Text]
  131. Mayrovitz HN and Roy J. Microvascular blood flow: evidence indicating a cubic dependence on arteriolar diameter. Am J Physiol Heart Circ Physiol 245: H1031–H1038, 1983.[Abstract/Free Full Text]
  132. McCully JD, Uematsu M, Parker RA, and Levitsky S. Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart. J Thorac Cardiovasc Surg 116: 154–162, 1998.[Abstract/Free Full Text]
  133. McKenzie JE, Steffen RP, and Haddy FJ. Relationships between adenosine and coronary resistance in conscious exercising dogs. Am J Physiol Heart Circ Physiol 242: H24–H29, 1982.[Abstract/Free Full Text]
  134. McKenzie JE, Steffen RP, and Haddy FJ. Effect of theophylline on adenosine production in the canine myocardium. Am J Physiol Heart Circ Physiol 252: H204–H210, 1987.[Abstract/Free Full Text]
  135. McRaven DR, Mark AL, Abboud FM, and Mayer HE. Responses of coronary vessels to adrenergic stimuli. J Clin Invest 50: 773–778, 1971.[Web of Science][Medline]
  136. Merkus D, Duncker DJ, and Chilian WM. Metabolic regulation of coronary vascular tone: role of endothelin-1. Am J Physiol Heart Circ Physiol 283: H1915–H1921, 2002.[Abstract/Free Full Text]
  137. Merkus D, Haitsma DB, Fung TY, Assen YJ, Verdouw PD, and Duncker DJ. Coronary blood flow regulation in exercising swine involves parallel rather than redundant vasodilator pathways. Am J Physiol Heart Circ Physiol 285: H424–H433, 2003.[Abstract/Free Full Text]
  138. Merkus D, Houweling B, Mirza A, Boomsma F, van den Meiracker AH, and Duncker DJ. Contribution of endothelin and its receptors to the regulation of vascular tone during exercise is different in the systemic, coronary and pulmonary circulation. Cardiovasc Res 59: 745–754, 2003.[Abstract/Free Full Text]
  139. Merrill GF, Downey HF, and Jones CE. Adenosine deaminase attenuates canine coronary vasodilation during systemic hypoxia. Am J Physiol Heart Circ Physiol 250: H579–H583, 1986.[Abstract/Free Full Text]
  140. Ming Z, Parent R, Thorin E, and Lavallee M. Endothelin-dependent tone limits acetylcholine-induced dilation of resistance coronary vessels after blockade of NO formation in conscious dogs. Hypertension 32: 844–848, 1998.[Abstract/Free Full Text]
  141. Miura H and Gutterman D. Human coronary arteriolar dilation to arachidonic acid depends on cytochrome P-450 monooxygenase and Ca2+-activated K+ channels. Circ Res 83: 501–507, 1998.[Abstract/Free Full Text]
  142. Miyashiro JK and Feigl EO. Feedforward control of coronary blood flow via coronary {beta}-receptor stimulation. Circ Res 73: 252–263, 1993.[Abstract/Free Full Text]
  143. Miyashiro JK and Feigl EO. A model of combined feedforward and feedback control of coronary blood flow. Am J Physiol Heart Circ Physiol 268: H895–H908, 1995.[Abstract/Free Full Text]
  144. Miyoshi Y, Nakaya Y, Wakatsuki T, Nakaya S, Fujino K, Saito K, and Inoue I. Endothelin blocks ATP-sensitive K+ channels and depolarizes smooth muscle cells of porcine coronary artery. Circ Res 70: 612–616, 1992.[Abstract/Free Full Text]
  145. Mohrman DE and Feigl EO. Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation. Circ Res 42: 79–86, 1978.[Free Full Text]
  146. Moncada S, Palmer RMJ, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109–142, 1991.[Web of Science][Medline]
  147. Mori H, Chujo M, Tanaka E, Yamakawa A, Shinozaki Y, Mohamed MU, and Nakazawa H. Modulation of adrenergic coronary vasoconstriction via ATP-sensitive potassium channel. Am J Physiol Heart Circ Physiol 268: H1077–H1085, 1995.[Abstract/Free Full Text]
  148. Morita K, Mori H, Tsujioka K, Kimura A, Ogasawara Y, Goto M, Hiramatsu O, Kajiya F, and Feigl EO. {alpha}-Adrenergic vasoconstriction reduces systolic retrograde coronary blood flow. Am J Physiol Heart Circ Physiol 273: H2746–H2755, 1997.[Abstract/Free Full Text]
  149. Murray PA and Vatner SF. {alpha}-Adrenoceptor attenuation of the coronary vascular response to severe exercise in the conscious dog. Circ Res 45: 654–660, 1979.[Free Full Text]
  150. Nakae I, Quan L, Sugimoto Y, Tsutamoto T, and Kinoshita M. Glibenclamide-induced oscillation of canine coronary artery is independent of myocardial ischemia. J Cardiovasc Pharmacol 23: 473–479, 1994.[Web of Science][Medline]
  151. Nakhostine N and Lamontagne D. Adenosine contributes to hypoxia-induced vasodilation through ATP-sensitive K+ channel activation. Am J Physiol Heart Circ Physiol 265: H1289–H1293, 1993.[Abstract/Free Full Text]
  152. Nayler WG and Carson V. Effect of stellate ganglion stimulation on myocardial blood flow, oxygen consumption, and cardiac efficiency during beta-adrenoceptor blockade. Cardiovasc Res 7: 22–29, 1973.[Web of Science][Medline]
  153. Nichols CG and Lederer WJ. Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol Heart Circ Physiol 261: H1675–H1686, 1991.[Abstract/Free Full Text]
  154. Niiya K, Uchida S, Tsuji T, and Olsson RA. Glibenclamide reduces the coronary vasoactivity of adenosine receptor agonists. J Pharmacol Exp Ther 271: 14–19, 1994.[Abstract/Free Full Text]
  155. Nishikawa Y and Ogawa S. Importance of nitric oxide in the coronary artery at rest and during pacing in humans. J Am Coll Cardiol 29: 85–92, 1997.[Abstract]
  156. Nishikawa Y, Stepp DW, and Chilian WM. In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation. Am J Physiol Heart Circ Physiol 277: H1252–H1259, 1999.[Abstract/Free Full Text]
  157. Nishikawa Y, Stepp DW, and Chilian WM. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol Heart Circ Physiol 279: H459–H465, 2000.[Abstract/Free Full Text]
  158. Noma A. ATP-regulated K+ channels in cardiac muscle. Nature 305: 147–148, 1983.[CrossRef][Medline]
  159. Oltman CL, Kane NL, Fudge JL, Weintraub NL, and Dellsperger KC. Endothelium-derived hyperpolarizing factor in coronary microcirculation: responses to arachidonic acid. Am J Physiol Heart Circ Physiol 281: H1553–H1560, 2001.[Abstract/Free Full Text]
  160. Orito K, Satoh K, and Taira N. Involvement of ATP-sensitive K+ channels in the sustained coronary vasodilator response to adenosine in dogs. Eur J Pharmacol 231: 183–189, 1993.[CrossRef][Web of Science][Medline]
  161. Pacold I, Hwang MH, Lawless CE, Diamond P, Scanlon PJ, and Loeb HS. Effects of indomethacin on coronary hemodynamics, myocardial metabolism and anginal threshold in coronary artery disease. Am J Cardiol 57: 912–915, 1986.[CrossRef][Web of Science][Medline]
  162. Parent R, Al-Obaidi M, and Lavallée M. Nitric oxide formation contributes to {beta}-adrenergic dilation of resistance coronary vessels in conscious dogs. Circ Res 73: 241–251, 1993.[Abstract/Free Full Text]
  163. Parent R, Hamdad N, Ming Z, and Lavallée M. Contrasting effects of blockade of nitric oxide formation on resistance and conductance coronary vessels in conscious dogs. Cardiovasc Res 31: 555–567, 1996.[CrossRef][Web of Science][Medline]
  164. Parent R and Lavallée M. Endothelin-dependent effects limit flow-induced dilation of conductance coronary vessels after blockade of nitric oxide formation in conscious dogs. Cardiovasc Res 45: 470–477, 2000.[Abstract/Free Full Text]
  165. Parent R, Paré R, and Lavallée M. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. Am J Physiol Heart Circ Physiol 262: H10–H16, 1992.[Abstract/Free Full Text]
  166. Parkington HC, Tonta MA, Coleman HA, and Tare M. Role of membrane potential in endothelium-dependent relaxation of guinea-pig coronary arterial smooth muscle. J Physiol 484: 469–480, 1995.[Abstract/Free Full Text]
  167. Pelc LR, Gross GJ, and Warltier DC. Mechanism of coronary vasodilation produced by bradykinin. Circulation 83: 2048–2056, 1991.[Abstract/Free Full Text]
  168. Popp R, Fleming I, and Busse R. Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor: a modulator of arterial compliance. Circ Res 82: 696–703, 1998.[Abstract/Free Full Text]
  169. Quillen J, Sellke F, Banitt P, and Harrison D. The effect of norepinephrine on the coronary microcirculation. J Vasc Res 29: 2–7, 1992.[Web of Science][Medline]
  170. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, and Cannon ROI. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 92: 320–326, 1995.[Abstract/Free Full Text]
  171. Randhawa MP, Lasley RD, and Mentzer RM Jr. Salutary effects of exogenous adenosine administration on in vivo myocardial stunning. J Thorac Cardiovasc Surg 110: 63–74, 1995.[Abstract/Free Full Text]
  172. Richmond KN, Tune JD, Gorman MW, and Feigl EO. Role of K+ATP channels in local metabolic coronary vasodilation. Am J Physiol Heart Circ Physiol 277: H2115–H2123, 1999.[Abstract/Free Full Text]
  173. Richmond KN, Tune JD, Gorman MW, and Feigl EO. Role of KATP+ channels and adenosine in the control of coronary blood flow during exercise. J Appl Physiol 89: 529–536, 2000.[Abstract/Free Full Text]
  174. Roberts PA, Newby AC, Hallett MB, and Campbell AK. Inhibition by adenosine of reactive oxygen metabolite production by human polymorphonuclear leucocytes. Biochem J 227: 669–674, 1985.[Web of Science][Medline]
  175. Rosolowsky M and Campbell WB. Synthesis of hydroxyeicosatetraenoic acids (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells. Biochim Biophys Acta 1299: 267–277, 1996.[Medline]
  176. Saetrum OO, Cantera L, Adner M, and Edvinsson L. Endothelin-A and -B receptors in human coronary arteries and veins. Regul Pept 63: 149–156, 1996.[CrossRef][Web of Science][Medline]
  177. Samaha FF, Heineman FW, Ince C, Fleming J, and Balaban RS. ATP-sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo. Am J Physiol Cell Physiol 262: C1220–C1227, 1992.[Abstract/Free Full Text]
  178. Seitelberger R, Guth BD, Heusch G, Lee JD, Katayama K, and Ross J Jr. Intracoronary {alpha}2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise. Circ Res 62: 436–442, 1988.[Abstract/Free Full Text]
  179. Sekili S, Jeroudi MO, Tang XL, Zughaib M, Sun JZ, and Bolli R. Effect of adenosine on myocardial ‘stunning’ in the dog. Circ Res 76: 82–94, 1995.[Abstract/Free Full Text]
  180. Shen W, Lundborg M, Wang J, Stewart JM, Xu X, Ochoa M, and Hintze TH. Role of EDRF in the regulation of regional blood flow and vascular resistance at rest and during exercise in conscious dogs. J Appl Physiol 77: 165–172, 1994.[Abstract/Free Full Text]
  181. Smith TP Jr and Canty JM Jr. Modulation of coronary autoregulatory responses by nitric oxide: evidence for flow-dependent resistance adjustments in conscious dogs. Circ Res 73: 232–240, 1993.[Abstract/Free Full Text]
  182. Standen NB, Quayle JM, Davies NW, Brayden JE, Huang Y, and Nelson MT. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science 245: 177–180, 1989.[Abstract/Free Full Text]
  183. Stepp DW, Kroll K, and Feigl EO. K+ATP channels and adenosine are not necessary for coronary autoregulation. Am J Physiol Heart Circ Physiol 273: H1299–H1308, 1997.[Abstract/Free Full Text]
  184. Stepp DW, Nishikawa Y, and Chilian WM. Regulation of shear stress in the canine coronary microcirculation. Circulation 100: 1555–1561, 1999.[Abstract/Free Full Text]
  185. Stepp DW, Van Bibber R, Kroll K, and Feigl EO. Quantitative relation between interstitial adenosine concentration and coronary blood flow. Circ Res 79: 601–610, 1996.[Abstract/Free Full Text]
  186. Sun D, Huang A, Mital S, Kichuk MR, Marboe CC, Addonizio LJ, Michler RE, Koller A, Hintze TH, and Kaley G. Norepinephrine elicits {beta}2-receptor-mediated dilation of isolated human coronary arterioles. Circulation 106: 550–555, 2002.[Abstract/Free Full Text]
  187. Takamura M, Parent R, Cernacek P, and Lavallée M. Influence of dual ETA/ETB-receptor blockade on coronary responses to treadmill exercise in dogs. J Appl Physiol 89: 2041–2048, 2000.[Abstract/Free Full Text]
  188. Takamura M, Parent R, and Lavallée B. Enhanced contribution of NO to exercise-induced coronary responses after {alpha}-adrenergic receptor blockade. Am J Physiol Heart Circ Physiol 282: H508–H515, 2002.[Abstract/Free Full Text]
  189. Tare M, Parkington HC, Coleman HA, Neild TO, and Dusting GJ. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature 346: 69–71, 1990.[CrossRef][Medline]
  190. Tayama S, Okumura K, Matsunaga T, Tsunoda R, Tabuchi T, Iwasa A, and Yasue H. Influence of chronic nitric oxide inhibition of coronary blood flow regulation. A study of the role of endogenous adenosine in anesthetized, open-chest dogs. Jpn Circ J 62: 371–378, 1998.[CrossRef][Medline]
  191. Thorin E, Parent R, Ming Z, and Lavallée M. Contribution of endogenous endothelin to large epicardial coronary artery tone in dogs and humans. Am J Physiol Heart Circ Physiol 277: H524–H532, 1999.[Abstract/Free Full Text]
  192. Thornton JD, Liu GS, Olsson RA, and Downey JM. Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 85: 659–665, 1992.[Abstract/Free Full Text]
  193. Tiefenbacher CP, DeFily DV, and Chilian WM. Requisite role of cardiac myocytes in coronary {alpha}1-adrenergic constriction. Circulation 98: 9–12, 1998.[Abstract/Free Full Text]
  194. Traverse JH, Judd D, and Bache RJ. Dose-dependent effect of endothelin-1 on blood flow to normal and collateral-dependent myocardium. Circulation 93: 558–566, 1996.[Abstract/Free Full Text]
  195. Traverse JH, Wang YL, Du R, Nelson D, Lindstrom P, Archer SL, Gong G, and Bache RJ. Coronary nitric oxide production in response to exercise and endothelium-dependent agonists. Circulation 101: 2526–2531, 2000.[Abstract/Free Full Text]
  196. Tune JD, Richmond KN, Gorman MW, and Feigl EO. Role of nitric oxide and adenosine in control of coronary blood flow in exercising dogs. Circulation 101: 2942–2948, 2000.[Abstract/Free Full Text]
  197. Tune JD, Richmond KN, Gorman MW, and Feigl EO. KATP+ channels, nitric oxide, and adenosine are not required for local metabolic coronary vasodilation. Am J Physiol Heart Circ Physiol 280: H868–H875, 2001.[Abstract/Free Full Text]
  198. Tune JD, Richmond KN, Gorman MW, Olsson RA, and Feigl EO. Adenosine is not responsible for local metabolic control of coronary blood flow in dogs during exercise. Am J Physiol Heart Circ Physiol 278: H74–H84, 2000.[Abstract/Free Full Text]
  199. Uematsu M, Gaudette GR, Laurikka JO, Levitsky S, and McCully JD. Adenosine-enhanced ischemic preconditioning decreases infarct in the regional ischemic sheep heart. Ann Thorac Surg 66: 382–387, 1998.[Abstract/Free Full Text]
  200. Van Bibber R, Stepp DW, Kroll K, and Feigl EO. The role of adenosine in norepinephrine-induced coronary vasodilation. Am J Physiol Heart Circ Physiol 273: H557–H565, 1997.[Abstract/Free Full Text]
  201. Van Bibber R, Traub O, Kroll K, and Feigl EO. EDRF and norepinephrine-induced coronary vasodilation in the canine coronary circulation. Am J Physiol Heart Circ Physiol 268: H1973–H1981, 1995.[Abstract/Free Full Text]
  202. Wang J, Wolin MS, and Hintze TH. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ Res 73: 829–838, 1993.[Abstract/Free Full Text]
  203. Wangler RD, Gorman MW, Wang CY, Dewitt DF, Chan IS, Bassingthwaighte JB, and Sparks HV. Transcapillary adenosine transport and interstitial adenosine concentration in guinea pig hearts. Am J Physiol Heart Circ Physiol 257: H89–H106, 1989.[Abstract/Free Full Text]
  204. Watkinson WP, Foley DH, Rubio R, and Berne RM. Myocardial adenosine formation with increased cardiac performance in the dog. Am J Physiol Heart Circ Physiol 236: H13–H21, 1979.[Free Full Text]
  205. Widmann MD, Weintraub NL, Fudge JL, Brooks LA, and Dellsperger KC. Cytochrome P-450 pathway in acetylcholine-induced canine coronary microvascular vasodilation in vivo. Am J Physiol Heart Circ Physiol 274: H283–H289, 1998.[Abstract/Free Full Text]
  206. Yada T, Richmond KN, Van Bibber R, Kroll K, and Feigl EO. Role of adenosine in local metabolic coronary vasodilation. Am J Physiol Heart Circ Physiol 276: H1425–H1433, 1999.[Abstract/Free Full Text]
  207. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415, 1988.[CrossRef][Medline]
  208. Zong P, Tune JD, Setty S, and Downey HF. Endogenous nitric oxide regulates right coronary blood flow during acute pulmonary hypertension in conscious dogs. Basic Res Cardiol 97: 392–398, 2002.[CrossRef][Web of Science][Medline]
  209. Zuberbuhler RC and Bohr DF. Responses of coronary smooth muscle to catecholamines. Circ Res 16: 431–440, 1965.[Abstract/Free Full Text]
  210. Zughaib ME, Abd-Elfattah AS, Jeroudi MO, Sun JZ, Sekili S, Tang XL, and Bolli R. Augmentation of endogenous adenosine attenuates myocardial ‘stunning’ independently of coronary flow or hemodynamic effects. Circulation 88: 2359–2369, 1993.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 HypertensionHome page
D. Xiao, S. Yang, and L. Zhang
Prenatal Cocaine Exposure Causes Sex-Dependent Impairment in the Myogenic Reactivity of Coronary Arteries in Adult Offspring
Hypertension, November 1, 2009; 54(5): 1123 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
E. Grossini, C. Molinari, D. A. S. G. Mary, F. Uberti, P. P. Caimmi, and G. Vacca
Intracoronary intermedin 1-47 augments cardiac perfusion and function in anesthetized pigs: role of calcitonin receptors and {beta}-adrenoreceptor-mediated nitric oxide release
J Appl Physiol, October 1, 2009; 107(4): 1037 - 1050.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Z. Bagi
Mechanisms of coronary microvascular adaptation to obesity
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2009; 297(3): R556 - R567.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. A. Mankoff, L. K. Dunnwald, S. C. Partridge, and J. M. Specht
Blood Flow-Metabolism Mismatch: Good for the Tumor, Bad for the Patient
Clin. Cancer Res., September 1, 2009; 15(17): 5294 - 5296.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
S. B. Bender, J. D. Tune, L. Borbouse, X. Long, M. Sturek, and M. H. Laughlin
Altered Mechanism of Adenosine-Induced Coronary Arteriolar Dilation in Early-Stage Metabolic Syndrome
Experimental Biology and Medicine, June 1, 2009; 234(6): 683 - 692.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
I. Heinonen, S. V. Nesterov, K. Liukko, J. Kemppainen, K. Nagren, M. Luotolahti, P. Virsu, V. Oikonen, P. Nuutila, U. M. Kujala, et al.
Myocardial blood flow and adenosine A2A receptor density in endurance athletes and untrained men
J. Physiol., November 1, 2008; 586(21): 5193 - 5202.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
W. Schaper
The Renaissance of Vascular Endothelial Growth Factor, Part B
Circ. Res., October 24, 2008; 103(9): 903 - 904.
[Full Text] [PDF]

Home page
 BloodHome page
M. T. Gladwin and D. B. Kim-Shapiro
The functional nitrite reductase activity of the heme-globins
Blood, October 1, 2008; 112(7): 2636 - 2647.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. Herget-Rosenthal
Reply
Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2702 - 2703.
[Full Text] [PDF]

Home page
 Physiol. Rev.Home page
D. J. Duncker and R. J. Bache
Regulation of Coronary Blood Flow During Exercise
Physiol Rev, July 1, 2008; 88(3): 1009 - 1086.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
E. Jebelovszki, C. Kiraly, N. Erdei, A. Feher, E. T. Pasztor, I. Rutkai, T. Forster, I. Edes, A. Koller, and Z. Bagi
High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2558 - H2564.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
V. J. de Beer, O. Sorop, D. A. Pijnappels, D. H. Dekkers, F. Boomsma, J. M. J. Lamers, D. J. Duncker, and D. Merkus
Integrative control of coronary resistance vessel tone by endothelin and angiotensin II is altered in swine with a recent myocardial infarction
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2069 - H2077.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. M. Dick, I. N. Bratz, L. Borbouse, G. A. Payne, U. D. Dincer, J. D. Knudson, P. A. Rogers, and J. D. Tune
Voltage-dependent K+ channels regulate the duration of reactive hyperemia in the canine coronary circulation
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2371 - H2381.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. T. Gladwin
Evidence Mounts That Nitrite Contributes to Hypoxic Vasodilation in the Human Circulation
Circulation, February 5, 2008; 117(5): 594 - 597.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. P. Dzeja, P. Bast, D. Pucar, B. Wieringa, and A. Terzic
Defective Metabolic Signaling in Adenylate Kinase AK1 Gene Knock-out Hearts Compromises Post-ischemic Coronary Reflow
J. Biol. Chem., October 26, 2007; 282(43): 31366 - 31372.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
T. Kawada, T. Yamazaki, T. Akiyama, M. Li, C. Zheng, T. Shishido, H. Mori, and M. Sugimachi
Angiotensin II attenuates myocardial interstitial acetylcholine release in response to vagal stimulation
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2516 - H2522.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. A. Kaufmann, O. E. Rimoldi, T. Gnecchi-Ruscone, T. F. Luscher, and P. G. Camici
Systemic nitric oxide synthase inhibition improves coronary flow reserve to adenosine in patients with significant stenoses
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2178 - H2182.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
D. J. Duncker and D. Merkus
Exercise hyperaemia in the heart: the search for the dilator mechanism
J. Physiol., September 15, 2007; 583(3): 847 - 854.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. J. Raher, H. Thibault, K. K. Poh, R. Liu, E. F. Halpern, G. Derumeaux, F. Ichinose, W. M. Zapol, K. D. Bloch, M. H. Picard, et al.
In Vivo Characterization of Murine Myocardial Perfusion With Myocardial Contrast Echocardiography: Validation and Application in Nitric Oxide Synthase 3 Deficient Mice
Circulation, September 11, 2007; 116(11): 1250 - 1257.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
D. J. C. Alders, R. N. Cornelussen, F. W. Prinzen, P. A. C. Specht, M. I. M. Noble, A. J. Drake-Holland, F. J. J. de Kanter, and J. H. G. M. van Beek
Heart/Cardiac Muscle: Regional sympathetic denervation affects the relation between canine local myocardial blood flow and oxygen consumption
Exp Physiol, May 1, 2007; 92(3): 541 - 548.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. P. Taylor, M. E. Olsen, and J. W. Starnes
Improved postischemic function following acute exercise is not mediated by nitric oxide synthase in the rat heart
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H601 - H607.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S.-i. Saitoh, C. Zhang, J. D. Tune, B. Potter, T. Kiyooka, P. A. Rogers, J. D. Knudson, G. M. Dick, A. Swafford, and W. M. Chilian
Hydrogen Peroxide: A Feed-Forward Dilator That Couples Myocardial Metabolism to Coronary Blood Flow
Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2614 - 2621.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. Merkus, O. Sorop, B. Houweling, B. A. Hoogteijling, and D. J. Duncker
KCa+ channels contribute to exercise-induced coronary vasodilation in swine
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2090 - H2097.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. A. Rogers, G. M. Dick, J. D. Knudson, M. Focardi, I. N. Bratz, A. N. Swafford Jr., S.-i. Saitoh, J. D. Tune, and W. M. Chilian
H2O2-induced redox-sensitive coronary vasodilation is mediated by 4-aminopyridine-sensitive K+ channels
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2473 - H2482.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. T. Gladwin, N. J. H. Raat, S. Shiva, C. Dezfulian, N. Hogg, D. B. Kim-Shapiro, and R. P. Patel
Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2026 - H2035.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. Merkus, D. B. Haitsma, O. Sorop, F. Boomsma, V. J. de Beer, J. M. J. Lamers, P. D. Verdouw, and D. J. Duncker
Coronary vasoconstrictor influence of angiotensin II is reduced in remodeled myocardium after myocardial infarction
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2082 - H2089.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. D. Tune
Withdrawal of vasoconstrictor influences in local metabolic coronary vasodilation
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2044 - H2046.
[Full Text] [PDF]

Home page
 Physiol. Rev.Home page
N. Westerhof, C. Boer, R. R. Lamberts, and P. Sipkema
Cross-talk between cardiac muscle and coronary vasculature.
Physiol Rev, October 1, 2006; 86(4): 1263 - 1308.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. M. Quayle, M. R. Turner, H. E. Burrell, and T. Kamishima
Effects of hypoxia, anoxia, and metabolic inhibitors on KATP channels in rat femoral artery myocytes
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H71 - H80.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
B. T. Larsen and D. D. Gutterman
Hypoxia, coronary dilation, and the pentose phosphate pathway
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2169 - H2171.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. A. Gupte and M. S. Wolin
Hypoxia promotes relaxation of bovine coronary arteries through lowering cytosolic NADPH
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2228 - H2238.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. G. Kingma Jr., C. Vincent, J. R. Rouleau, and I. Kingma
Influence of Acute Renal Failure on Coronary Vasoregulation in Dogs
J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1316 - 1324.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
E. Fosslien
Cardiovascular Complications of Non-Steroidal Anti-Inflammatory Drugs
Ann. Clin. Lab. Sci., October 1, 2005; 35(4): 347 - 385.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
P. Zong, J. D. Tune, and H. F. Downey
Mechanisms of Oxygen Demand/Supply Balance in the Right Ventricle
Experimental Biology and Medicine, September 1, 2005; 230(8): 507 - 519.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. A. Grayburn
Stress Echo Without the Stress: Detection of Coronary Stenosis at Rest by Myocardial Contrast Echocardiography
Circulation, August 23, 2005; 112(8): 1085 - 1087.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Neishi, S. Mochizuki, T. Miyasaka, T. Kawamoto, T. Kume, R. Sukmawan, M. Tsukiji, Y. Ogasawara, F. Kajiya, T. Akasaka, et al.
Evaluation of bioavailability of nitric oxide in coronary circulation by direct measurement of plasma nitric oxide concentration
PNAS, August 9, 2005; 102(32): 11456 - 11461.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. S. Wolin, M. Ahmad, and S. A. Gupte
Oxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, and potential importance of cytosolic NADPH
Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L159 - L173.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. D. Knudson, U. D. Dincer, C. Zhang, A. N. Swafford Jr., R. Koshida, A. Picchi, M. Focardi, G. M. Dick, and J. D. Tune
Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H48 - H56.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. T. Gladwin
Hemoglobin as a Nitrite Reductase Regulating Red Cell-Dependent Hypoxic Vasodilation
Am. J. Respir. Cell Mol. Biol., May 1, 2005; 32(5): 363 - 366.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. C. Ejike, L. S. L. Arakaki, D. A. Beard, W. A. Ciesielski, E. O. Feigl, and K. A. Schenkman
Myocardial oxygenation and adenosine release in isolated guinea pig hearts during changes in contractility
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2062 - H2067.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. Zhang, J. D. Knudson, S. Setty, A. Araiza, U. D. Dincer, L. Kuo, and J. D. Tune
Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2154 - H2162.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. Farias III, M. W. Gorman, M. V. Savage, and E. O. Feigl
Plasma ATP during exercise: possible role in regulation of coronary blood flow
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1586 - H1590.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. W. Gorman, M. Farias III, K. N. Richmond, J. D. Tune, and E. O. Feigl
Role of endothelin in {alpha}-adrenoceptor coronary vasoconstriction
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1937 - H1942.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
R. Bugiardini and C. N. Bairey Merz
Angina With "Normal" Coronary Arteries: A Changing Philosophy
JAMA, January 26, 2005; 293(4): 477 - 484.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
D. J Green, A. Maiorana, G. O'Driscoll, and R. Taylor
Effect of exercise training on endothelium-derived nitric oxide function in humans
J. Physiol., November 15, 2004; 561(1): 1 - 25.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (72)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tune, J. D.
Right arrow Articles by Feigl, E. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tune, J. D.
Right arrow Articles by Feigl, E. O.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.